Successful treatment of relapsed KMT2A rearranged AML with central nervous system involvement using revumenib in combination with venetoclax and azacitidine: A case report
This case report describes the successful treatment of a patient with acute monocytic leukemia (AML-M5), positive for the KMT2A::AFDN fusion gene, who relapsed and developed central nervous system involvement after allogeneic hematopoietic stem cell transplantation. The patient was a 32-year-old male initially treated...